Chemotargets

Chemotargets was founded in 2006 as a spin-off of the systems pharmacology research group of Dr. Jordi Mestres under the auspices of the IMIM Hospital del Mar Medical Research Institute. The company, with headquarters located in the Barcelona Science Park (PCB), offers state-of-the-art artificial intelligence-driven methodologies with predictive capabilities in the fields of virtual screening, chemical design, pharmacology and drug safety. Its goal is to help the pharmaceutical industry accelerate drug discovery and development programs, while improving cost-effectiveness and safety.